3chinaM

Chinese corporate bond’s yields spike signalling more stimulus is needed

Bonds

Summary:  Investors crowded the issuance of euro-denominated Chinese government bonds yesterday, pushing yields of 5-year notes below zero. They might be betting that the People's Bank of China will ease the economy further even though it seems on the way to recovery. Indeed, some signals in the corporate space point to troubles ahead. Industrial corporate yields spiked this month signalling more defaults, which might ultimately weigh on the financial system. At the same time selling momentum in Chinese government bonds is picking up. A spike in government bond yields might deteriorate further corporate spreads, and the central bank might not have other option than intervening.


Yesterday, China issued for the first time in a year euro-denominated debt. The offering amounted to €4bn spread across 5-, 10- and 15-year maturities, however, attracted more than €17bn in bids. The new bonds add to the €4bn notes issued last year across 7-, 12- and 20-year maturity.

Interestingly, the 5-year bonds were issued with a negative yield of -0.15%, while the rest of the debt offering carried a positive yield yet, well below 1%.

Besides the Chinese economy's recovery story, there might be another reason behind the high demand in Chinese sovereigns. Indeed, the recent spike of Chinese Industrial corporates' yields shows that there are troubles ahead and that the People’s Bank of China (PBoC) will need to stimulate the economy further to avoid a liquidity squeeze within the corporate bond space.

19_11_2020-AS1

The sudden spike of corporate bond yields is happening precisely at the same time as yields in China’s 10-year government bonds are rising. To put more pressure on increasing yields, the Relative Strength Index (RSI) shows that the 10-year sovereigns are overbought and that selling momentum is approaching.

19_11_2020-AS2
Source: Bloomberg

It is therefore doubtful that the PBoC will stay watching as a selloff in Chinese sovereigns might correspond with a fast widening of Chinese corporate spreads.

According to the latest annual Financial Stability Report published by the PBoC in November, the non-performing loan (NPL) ratio of 30 sample banks is expected to surge around 5% at the end of this year, 5.5% in 2021 and 6.7% in 2022. These numbers are well above the 1.5% recorded at the end of the first quarter of 2020. Higher NPL numbers don't constitute an issue only for the corporate space, but also for banks. The report shows that a third of the Chinese banks monitored by the PBoC's fail the central bank's stress test. A big part of them needs to raise capital or loss-absorbing debt to fulfil their total loss-absorbing capacity (TLAC).

It explains why just a couple of days ago, the PBoC has injected 800bn yuan in the Medium-term Lending Facilities (MLF) in the credit market. Even though a few days ago, Guoqiang Liu, vice governor of the PBoC,  said that the central bank would "sooner or later exit" stimulus policies set in place for the Covid-19 pandemic, it is clear that at the moment it would be risky for the central bank to taper.

The question is whether the PBoC might tighten the economy further in order to avoid rising defaults which would inevitably weigh on the financial sector.

So far, the message of the central bank seems to steer away from a dovish tone. However, the facts are pointing to more stimulus. Bloomberg reported today that the PBoC had injected 70bn yuan into the banking system using 7-day reverse repurchase agreements to increase liquidity in the market. It definitively doesn't look like a central bank that is on the verge of easing the economy, and investors might be right to see an upside Chinese sovereigns.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.